Ellen V. Chiniara's most recent trade in Compass Therapeutics Inc was a trade of 90,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 27,500 | 82,326 | - | 0 | Common Stock | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 03 Mar 2025 | 1,833 | 80,493 | - | 30.3 | 55,590 | Common Stock |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 31.00 per share. | 03 Mar 2025 | 408 | 80,085 | - | 31.0 | 12,650 | Common Stock |
| Compass Therapeutics Inc | Ellen V. Chiniara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Ellen V. Chiniara | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 06 Jan 2025 | 3,129 | 54,826 | - | 41.8 | 130,645 | Common Stock |